{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:48:04Z","timestamp":1780526884908,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03717-3","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T09:25:27Z","timestamp":1737019527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Short-term efficacy and safety of upadacitinib combined with 308 excimer light versus upadacitinib alone and 308 excimer light alone in patients with progressing facial vitiligo"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1324-2215","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengrui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfa","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoumin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"3717_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.5114\/ada.2021.108896","volume":"38","author":"T Iwanowski","year":"2021","unstructured":"Iwanowski T, Szl\u0105zak P, Zab\u0142otna M, Olszewska B, Soko\u0142owska-Wojdy\u0142o M (2021) Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Polish. Postep Dermatologii i Alergol 38:636\u2013643","journal-title":"Postep Dermatologii i Alergol"},{"key":"3717_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163806","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Cai Y, Shi M, Jiang S, Cui S, Wu Y, Gao XH, Chen HD (2016) The prevalence of vitiligo: a meta-analysis. PLoS ONE 11:e0163806","journal-title":"PLoS ONE"},{"issue":"11","key":"3717_CR3","doi-asserted-by":"publisher","first-page":"9749","DOI":"10.3390\/ijms24119749","volume":"24","author":"T Iwanowski","year":"2023","unstructured":"Iwanowski T, Ko\u0142kowski K, Nowicki RJ, Soko\u0142owska-Wojdy\u0142o M (2023) Etiopathogenesis and emerging methods for treatment of vitiligo. Int J Mol Sci 24(11):9749","journal-title":"Int J Mol Sci"},{"key":"3717_CR4","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2174\/1389450123666220406125645","volume":"23","author":"A Chaudhary","year":"2022","unstructured":"Chaudhary A, Patel M, Singh S (2022) Current debates on etiopathogenesis and treatment strategies for vitiligo. Curr Drug Targets 23:1219\u20131238","journal-title":"Curr Drug Targets"},{"key":"3717_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/jdv.17742","volume":"36","author":"J Shourick","year":"2022","unstructured":"Shourick J, Seneschal J, Andreu N, Meurant JM, Pane I, Ravaud P, Tran VT, Ezzedine K (2022) Vitiligo treatment impact score (VITs): development and validation of a vitiligo burden of treatment questionnaire using the ComPaRe Vitiligo e-cohort. J Eur Acad Dermatol Venereol 36:279\u2013285","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3717_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.09.003","volume":"81","author":"H Xie","year":"2016","unstructured":"Xie H, Zhou F, Liu L, Zhu G, Li Q, Li C, Gao T (2016) Vitiligo: how do oxidative stress-induced autoantigens trigger autoimmunity? J Dermatol Sci 81:3\u20139","journal-title":"J Dermatol Sci"},{"key":"3717_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jid.2016.09.016","volume":"137","author":"JM Richmond","year":"2017","unstructured":"Richmond JM, Bangari DS, Essien KI, Currimbhoy SD, Groom JR, Pandya AG, Youd ME, Luster AD, Harris JE (2017) Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease. J Invest Dermatol 137:350\u2013358","journal-title":"J Invest Dermatol"},{"issue":"14","key":"3717_CR8","doi-asserted-by":"publisher","first-page":"1112811","DOI":"10.3389\/fimmu.2023.1112811","volume":"24","author":"R Speeckaert","year":"2023","unstructured":"Speeckaert R, Belpaire A, Speeckaert MM, van Geel N (2023) A meta-analysis of chemokines in vitiligo: recruiting immune cells towards melanocytes. Front Immunol 24(14):1112811","journal-title":"Front Immunol"},{"issue":"5","key":"3717_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028303","volume":"9","author":"F G\u00f3mez-Garc\u00eda","year":"2019","unstructured":"G\u00f3mez-Garc\u00eda F, G\u00f3mez-Arias PJ, Hernandez J, Montilla AM, Gay-Mimbrera J, Aguilar-Luque M, Viguera-Guerra I, Velez Garc\u00eda-Nieto A, Isla-Tejera B, Ruano J (2019) Drugs targeting the JAK\/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review. BMJ Open 9(5):e028303","journal-title":"BMJ Open"},{"issue":"11","key":"3717_CR10","volume":"5","author":"N Boukhedouni","year":"2020","unstructured":"Boukhedouni N, Martins C, Darrigade AS et al (2020) Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo. JCI Insight 5(11):e133772","journal-title":"JCI Insight"},{"issue":"5","key":"3717_CR11","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.3390\/ijms24054910","volume":"24","author":"F Diotallevi","year":"2023","unstructured":"Diotallevi F, Gioacchini H, De Simoni E, Marani A, Candelora M, Paolinelli M, Molinelli E, Offidani A, Simonetti O (2023) Vitiligo, from pathogenesis to therapeutic advances: state of the art. Int J Mol Sci 24(5):4910","journal-title":"Int J Mol Sci"},{"issue":"23","key":"3717_CR12","first-page":"02410","volume":"S0190\u20139622","author":"X Su","year":"2023","unstructured":"Su X, Luo R, Ruan S, Zhong Q, Zhuang Z, Xiao Z, Zhang P, Cheng B, Gong T, Ji C (2023) Efficacy and safety of oral upadacitinib monotherapy in patients with recalcitrant vitiligo. J Am Acad Dermatol S0190\u20139622(23):02410\u201302416","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3717_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/09546634.2020.1735615","volume":"33","author":"K Phan","year":"2022","unstructured":"Phan K, Phan S, Shumack S, Gupta M (2022) Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and meta-analysis. J Dermatolog Treat 33(1):173\u2013177","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"3717_CR14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2017.05.043","volume":"77","author":"LY Liu","year":"2017","unstructured":"Liu LY, Strassner JP, Refat MA, Harris JE, King BA (2017) Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure. J Am Acad Dermatol 77(4):675-682.e1","journal-title":"J Am Acad Dermatol"},{"key":"3717_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jaad.2019.04.032","volume":"81","author":"J McKesey","year":"2019","unstructured":"McKesey J, Pandya AG (2019) A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo. J Am Acad Dermatol 81:646\u2013648","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3717_CR16","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jaad.2018.02.023","volume":"78","author":"D Joshipura","year":"2018","unstructured":"Joshipura D, Alomran A, Zancanaro P, Rosmarin D (2018) Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: a 32-week open-label extension study with optional narrow-band ultraviolet B. J Am Acad Dermatol 78(6):1205-1207.e","journal-title":"J Am Acad Dermatol"},{"issue":"46","key":"3717_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jdcr.2024.01.033","volume":"21","author":"J Magdaleno-Tapial","year":"2024","unstructured":"Magdaleno-Tapial J, Hern\u00e1ndez-Bel P, Esteve-Mart\u00ednez A, Pe\u00f1uelas-Leal R, Labrandero-Hoyos C, S\u00e1nchez-Carazo JL, P\u00e9rez-Ferriols A (2024) Upadacitinib and its role in the treatment of vitiligo: a new possible therapeutic perspective. JAAD Case Rep 21(46):57\u201358","journal-title":"JAAD Case Rep"},{"issue":"73","key":"3717_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102655","volume":"31","author":"T Passeron","year":"2024","unstructured":"Passeron T, Ezzedine K, Hamzavi I, van Geel N, Schlosser BJ, Wu X, Huang X, Soliman AM, Rosmarin D, Harris JE, Camp HS, Pandya AG (2024) Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study. EClinicalMedicine 31(73):102655","journal-title":"EClinicalMedicine"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03717-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03717-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03717-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T09:25:28Z","timestamp":1737019528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03717-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3717"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03717-3","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Confirm that the written informed consent of all individuals (or their legal guardians) in the picture has been obtained. Prior to submitting the manuscript, the authors secured written consent from multiple patients to publish their photos both in print and online, acknowledging that this information might be made public. Nevertheless, a considerable proportion of patients do not consent to the publication of clinical photos taken during visits in journals. Our manuscript solely presents clinical photographs of patients who have signed informed consent forms. The patient consent form was not provided to the journal, but was retained by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"252"}}